GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Luoxin Pharmaceuticals Group Stock Co 002793.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

4.06

-0.73%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Luoxin Pharmaceuticals Group Stock Co

Its shares trade on Shenzhen under the ticker 002793.SZ. It has been listed since 15 April 2016. In the fiscal year to 31 December 2024, it reported revenue of CN¥2.65bn and a net loss of CN¥965.5m. At that date it held total assets of CN¥4.34bn and shareholders' equity of CN¥1.38bn.

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company is headquartered in Linyi, Shandong. The company went IPO on 2016-04-15. The firm operates two segments. The Pharmaceutical Industry segment is engaged in the research and development, manufacturing and sales of chemical drug preparations and raw and auxiliary drugs. Its main products are digestive drugs, respiratory drugs and antibiotic drugs, among others. The Pharmaceutical Business segment is engaged in the sales and logistics of agent drugs and medical devices. The firm conducts its businesses in the domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
15 Apr 2016
Employees
4,582
Website
luoxin.cn ↗

Leadership

Pay as last reported

  • Mr. Zhenteng LiuChairman of the Board, General Manager, since 2023CN¥1.8m
  • Mr. Yongsheng WuFinance Director
  • Mr. Bohong SunDeputy General ManagerCN¥1.7m
  • Mr. Xiaotong ZhuDeputy General ManagerCN¥3.8m
  • Mr. Fengsheng HanSecretary of the BoardCN¥169,700
  • Mr. Zhenfei LiuDirectorCN¥826,500
  • Mr. Yunpei GuoIndependent DirectorCN¥53,300
  • Mr. Zhi'ang WuIndependent DirectorCN¥80,000
  • Ms. Xia XuIndependent DirectorCN¥80,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Luoxin Pharmaceuticals Group employs 4,582 full-time employees in Linyi, Shandong.
  • The company's Pharmaceutical Industry segment produces digestive, respiratory, and antibiotic drugs.
  • Luoxin's domestic market operations focus on chemical drug preparations and raw materials.

Weaknesses

  • The company's business is limited to the domestic market in China.
  • Luoxin's Pharmaceutical Business segment relies on agent drugs and medical devices sales.
  • The firm has no international presence beyond China's domestic market.

Opportunities

  • Expanding into the domestic market for chemical drug preparations and raw materials.
  • Increasing sales of digestive, respiratory, and antibiotic drugs in China.
  • Growing demand for pharmaceutical products in Shandong Province.

Threats

  • Competition from other domestic pharmaceutical companies in China.
  • Regulatory changes affecting the pharmaceutical industry in China.
  • Economic downturns impacting domestic healthcare spending in China.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.